Navigation Links
Solutions for Parents Who Need Cold Remedies for Their Children
Date:1/18/2008

Safe products available in light of FDA's Advisory

ALBUQUERQUE, N.M., Jan. 18 /PRNewswire/ -- Yesterday the FDA issued a Public Health Advisory to parents recommending that over-the-counter (OTC) cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use. According to the FDA's news release there are a wide variety of rare, serious, and adverse events reported with cough and cold products. They include convulsions, rapid heart rates, decreased levels of consciousness and death. This news leaves parents of young children wondering what options are available.

Parents do have alternatives. Heel (a manufacturer of homeopathic drugs) offers safe, effective and natural medicines for infants and children suffering from common cold and flu symptoms. Physicians may confidently recommend many Heel medicines for their young patients including Viburcol(R) pediatric oral drops for restlessness and fever; Nectadyn(TM) cough syrup (formerly sold as CoughFree) for coughs (recommended for ages 2 and up); Sinusin(TM) nasal spray (also sold as Euphorbium Sinus Relief(TM)) for nasal congestion; and Traumeel(R) Ear Drops for ear pain and inflammation.

These products act rapidly to soothe and comfort children without adverse risks. Bruce Shelton, MD, MD(h), DiHom, FBIH, noted Homeopathic Family Physician in Phoenix, Ariz., commented, "Since learning how effective homeopathics are, I give all of my pediatric patients liquid complex homeopathic preparations and I see dramatic recoveries in short amounts of time without the recurrent infections seen so commonly with traditional methods." An article that appeared in Natural Solutions magazine (January, 2008) offered options of many safe homeopathic and herbal approaches. Roy Steinbock, MD, a holistic pediatrician with a practice in Boulder, Colo. recommends Heel's Euphorbium Sinus Relief(TM) nasal spray (also sold as Sinusin(TM)) for all ages, including infants.

Viburcol(R) has been clinically researched and is comparable to acetaminophen for the symptomatic treatment of acute feverish infections in children under the age of 12(1). CoughFree, has been a staple in family medicine chests as an alternative to over-the-counter cough suppressants. Both Traumeel(R) and Euphorbium Sinus Relief(TM) have been used by practitioners and their patients alike for decades due to their effective and complete relief. These products are available through health care practitioners, pharmacies and health food stores.

Heel Inc. is the U.S. subsidiary of Heel GmbH, which is one of the world's largest homeopathic pharmaceutical manufacturers with distribution in over 60 countries. For more information on other Heel products and their efficacy please visit http://www.heelusa.com.

(1.) Muller-Krampe B et al. Symptomatic treatment of acute feverish

infections with a modern homeopathic medication. Biological Medicine

2002; Vol.31.No.2: 79-85.


'/>"/>
SOURCE Heel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit
2. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
3. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
4. SXC Health Solutions to present at the 2007 UBS Global Life Sciences Conference
5. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
6. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
7. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
8. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
9. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
10. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
11. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/23/2017)... , ... April 23, 2017 , ... ... managed services announced the achievement of Cisco Select certification and SMB specialization. ... United States. , In earning the Select Certification, Altura fulfilled the ...
(Date:4/22/2017)... (PRWEB) , ... April 22, ... ... Administration of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its ... Heron-Doerr, PROSHRED® Philadelphia specializes in providing information destruction , recycling, ...
(Date:4/22/2017)... ... 22, 2017 , ... Brian Emmer brings more than 25 ... Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for the leadership ... for the company. Recognized industry-wide as a healthcare innovator, Emmer has executive ...
(Date:4/21/2017)... ... ... An April 10 article in the Daily Mail describes the ... deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, painful techniques. ... dental matter, and that teeth were then filled with bitumen, a substance similar to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: